The year 2014 was a transition and execution year for Galapagos.

Onno van de Stolpe, CEO

Letter from the CEO

Galapagos greatly expanded its pipeline in 2014

Read more

Financial highlights

Group revenues


Read more

Cash position



Read more


Galapagos seeks to develop clinical-stage breakthrough therapies.

Read more